Tag: abeona therapeutics
September 23, 2019
Abeona to Submit More Data to FDA Before Starting Phase 3 Trial
Following the announcement, shares of Abeona Therapeutics tumbled nearly 12 percent in Monday's trading session.
September 8, 2019
5 Top Weekly NASDAQ Biotech and Pharma Stocks: Abeona Rises 66 Percent
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have... June 18, 2019
Abeona Therapeutics Receives FDA Fast Track Designation for ABO-202 AAV9 Gene Therapy
Abeona Therapeutics (NASDAQ:ABEO) has announced that the US Food and Drug Administration (FDA) has granted the company fast track designation... April 30, 2019
Abeona Therapeutics Presents New Preclinical Data of ABO-401
Abeona Therapeutics announced the presentation of new preclinical data on its candidate ABO-401. December 7, 2018
Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs
Abeona Therapeutics (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic... April 23, 2018
Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA
Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic... April 20, 2018